Showing results (91-100 of 121) with videos related to

Sort By:
Pageof 13
Neoplasia (New York, N.Y.)|December 18, 2007
Inhibition of epidermal growth factor receptor and vascular endothelial growth factor receptor phosphorylation on tumor-associated endothelial cells leads to treatment of orthotopic human colon cancer in nude miceTakamitsu Sasaki, Yasuhiko Kitadai, Toru Nakamura, et al.
International Immunopharmacology|January 22, 2011
Consistent interactions between tumor cell IL-6 and macrophage TNF-α enhance the growth of human prostate cancer cells in the bone of nude mouseSeung Wook Kim, Jang Seong Kim, John Papadopoulos, et al.
Cancer Research|November 3, 2004
Tumor cell and endothelial cell therapy of oral cancer by dual tyrosine kinase receptor blockadeOrhan G Yigitbasi, Maher N Younes, Dao Doan, et al.
International Journal of Oncology|October 8, 2005
Serum amyloid A as a tumor marker in sera of nude mice with orthotopic human pancreatic cancer and in plasma of patients with pancreatic cancerKenji Yokoi, Li-Chen Nancy Shih, Ryuji Kobayashi, et al.
The Prostate|October 3, 2006
Therapy of multidrug resistant human prostate tumors in the prostate of nude mice by simultaneous targeting of the epidermal growth factor receptor and vascular endothelial growth factor receptor on tumor-associated endothelial cellsJ Erik Busby, Sun-Jin Kim, Sertac Yazici, et al.
Translational Oncology|February 21, 2012
Antivascular therapy for multidrug-resistant ovarian tumors by macitentan, a dual endothelin receptor antagonistSun-Jin Kim, Jang Seong Kim, Seung Wook Kim, et al.
Cancer Research|May 4, 2005
Dual inhibition of epidermal growth factor receptor and vascular endothelial growth factor receptor phosphorylation by AEE788 reduces growth and metastasis of human colon carcinoma in an orthotopic nude mouse modelKenji Yokoi, Premal H Thaker, Sertac Yazici, et al.
Molecular Cancer Therapeutics|October 5, 2007
Expression of epidermal growth factor (EGF)/transforming growth factor-alpha by human lung cancer cells determines their response to EGF receptor tyrosine kinase inhibition in the lungs of miceWenjuan Wu, Michael S O'Reilly, Robert R Langley, et al.
Clinical & Experimental Metastasis|March 8, 2008
Targeting the EGFR, VEGFR, and PDGFR on colon cancer cells and stromal cells is required for therapyToshio Kuwai, Toru Nakamura, Takamitsu Sasaki, et al.
Neoplasia (New York, N.Y.)|May 14, 2008
Phosphorylated epidermal growth factor receptor on tumor-associated endothelial cells is a primary target for therapy with tyrosine kinase inhibitorsToshio Kuwai, Toru Nakamura, Takamitsu Sasaki, et al.
Pageof 13